Building a dose toxo-equivalence model from a Bayesian meta-analysis of published clinical trials

DOI10.1214/23-AOAS1748OpenAlexW4388087117MaRDI QIDQ6138617FDOQ6138617

Authors:

Publication date: 16 January 2024

Published in: The Annals of Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1214/23-aoas1748

zbMATH Keywords

Bayesian methodsdose toxo-equivalenceindividual patient data meta-analysisstudy-level meta-analysis

Mathematics Subject Classification ID

Applications of statistics (62Pxx)

Cites Work

• Title not available (Why is that?)
• Title not available (Why is that?)
• Comparison of Meta-Analysis Versus Analysis of Variance of Individual Patient Data
• Integrated likelihood methods for eliminating nuisance parameters. (With comments and a rejoinder).
• Likelihood functions for inference in the presence of a nuisance parameter
• On random-effects meta-analysis
• On the relative efficiency of using summary statistics versus individual-level data in meta-analysis
• Prior distributions for variance parameters in hierarchical models (Comment on article by Browne and Draper)

This page was built for publication: Building a dose toxo-equivalence model from a Bayesian meta-analysis of published clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6138617)